Skip to content
OpenCapital
Get started

Supernus Pharmaceuticals SUPN Selling Expense

Selling Expense at other companies

Balchem logo
BalchemBCPC
$21.1M+24.6%
United Airlines Holdings logo
United Airlines HoldingsUAL
$522M+5.2%
Abercrombie & Fitch logo
Abercrombie & FitchANF
$431.2M+7.8%
Installed Building Products logo
Installed Building ProductsIBP
$34M-4.0%
HTF
Heartflow, Inc. Common StockHTFL
$18.93M+13.2%
Nuvation Bio logo
Nuvation BioNUVB
$375K—

Segments

By segment

See full
Reportable Segment$66.28M+55.5%

Other financials

Income statement

See full
Revenue$207.7M+38.6%
Gross profit$184.3M+37.5%
Operating income-$8.3M+18.8%
Net income-$2.3M+80.6%
EPS (diluted)-$0.04+81.0%

Balance sheet

See full
Cash & equivalents$186.3M+60.8%
Total debt$40.9M+26.6%
Total equity$1.1B+4.5%
Total assets$1.5B+11.4%

Cash flow

See full
Operating cash flow$66.5M+117%
CapEx--100%
Free cash flow$66.5M+120%

Valuation

See full
Market cap$2.62B+62.8%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-7.8%-18.9pp
Net margin-3.7%-13.0pp
FCF margin27.9%+3.4pp

Returns & leverage

See full
Return on equity-2.8%-9.1pp
Debt / equity0×0.0×
Current ratio2×-0.5×